News

Health on MSN9h
Nationwide Recall Hits Dozens of Common Generic Drugs—What You Need to Know
Dozens of generic medications—including some to treat conditions like high blood pressure, allergies, and high cholesterol—have been recalled.A Glenmark Pharmaceuticals factory in India did not meet ...
Health11h
The FDA Just Updated This Nationwide Chocolate Recall—Here’s What You Need to Know
Chocolate bars recalled nationwide earlier in April were given a Class II classification by the Food and Drug Administration, the agency announced Tuesday. Two flavors of Tony's Chocolonely chocolate ...
Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis
Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in ...
Scilex confirms FDA awards orphan drug designation for colchicine
Scilex (SCLX) announced that FDA has approved the company’s request for the orphan drug designation for colchicine for the treatment of ...
Tony's Chocolonely Recall Update As FDA Sets Risk Level
Two Tony's Chocolonely products were recalled nationwide after multiple consumers outside North America reported finding small stones in the items.
Pharmaceutical Technology on MSN6d
FDA approves injectable antibiotics for B Braun drug delivery system
The US Food and Drug Administration (FDA) has approved the injectable antibiotics Piperacillin and Tazobactam for use in B ...
FDA updates health risk for recalled Lean Cuisine sold nationwide, including N.Y.
The recall affected batches of Lean Cuisine butternut squash ravioli, spinach artichoke ravioli, lemon garlic shrimp stir fry ...
technologynetworks15d
First-in-Class Drugs Offered Greater Regulatory Flexibility in the US vs Europe
A new comparison of approval data for first-in-class drugs approved by the US Food and Drug Administration (FDA) and those approved by the European Medicines Agency (EMA) revealed that the FDA is more ...
FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals
Apellis' Empaveli receives FDA Priority Review for rare kidney diseases C3G and IC-MPGN. Phase 3 data show strong efficacy in ...
Benzinga.com15d
FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals
The FDA granted Priority Review to Apellis' sNDA ... Cites Longer Peak Sales Timing For Syfovre The Prescription Drug User Fee Act (PDUFA) target action date is July 28, 2025.
Phys.org16d
A classification of drugs based on their environmental impact
The proposed list is subject to change when new data becomes available, their rarity being a limiting factor for classification. Every day in Western countries, thousands of drugs are consumed ...